Answers are grounded in this paper and cite their sources.
Acquired immunodeficiency syndrome (AIDS) is the most devastating pandemic in recent history of the mankind. It takes a heavy toll of life and is a major deterrent to the economic development of many countries. Human Immunodeficiency Virus type 1 (HIV-1) reverse transcriptase is an important target for chemotherapeutic agents against this devastating disease. Nucleoside Reverse Transcriptase Inhibitors (NRTI) are known to be the best drugs as it causes chain termination hindering further viral protein synthesis. Rational design of NRTIs has become one of the most important activities in the pharmaceutical industry. Keeping in mind the fast viral mutation and increasing demand of improving the drug combination for HAART therapy, there is an urge for new drug synthesis of the same series. To get an insight about the right structural features needed to develop the NRTIs, 2D-QSAR and docking studies were carried out. CODESSA was used for QSAR study while SYBYL (FlexX) and GOLD were used to carry out the docking studies. 30 molecules were considered in the study. Among them, they were divided into training (21) and test set (9). The best QSAR model is obtained with an r2 value of 0.9516 and q2 value of 0.8544 with seven descriptors. This study will give a deep insight to understand the major role played by the descriptors of NRTI drugs and their binding efficiency in ligand drug interaction.
No takes yet. Share an insight, caveat, or question.
A 2007 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: